M
Medley
Human resource and medical SaaS platforms for healthcare
At a glance
- Status
- Listed
- Founded
- 2009
- Headquarters
- Tokyo, Japan
- Listing
- IPO 2019
- Sector
- Health Tech & Medtech
- Power Law
- Thoroughbred$100M+ revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
- NCNissay Capital
- IFIncubate Fund
East Ventures
Series B and later8 investors entered at this stage
- GPGlobis Capital Partners
- SBSMBC Trust Bank
- MRMRT
- KPKaigen Pharma
- GRGREE
- NVNTT DOCOMO Ventures
- GCGlobal Brain Corporation
- NPNikkei Business Publications
Source: Dealroom Talent Intelligence.
Global footprint
across markets
Investments and acquisitions
Disclosed deals where Medley was the backer or acquirer, 2022–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
5 deals across Medley's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Medley's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Medley on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Medley on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.